From Danone's half-year results to NMN boom in Hong Kong and Orthomol's phenomenal success in South Korea, here are the most-read stories on NutraIngredients-Asia in August 2024.
Danone is doubling down on its specialised nutrition offerings, including infant formula and Foods for Special Medical Purposes (FSMP) for China, a market which it said has delivered “stellar performance” for the first half of 2024.
Nicotinamide mononucleotide (NMN) has become one of the hottest health supplement categories in Hong Kong, on the back of strong demand for anti-ageing products, say Catalo, NUNMN, and Homart in this edition of our in-depth VitamINSIGHTS analysis.
German food supplement company Orthomol believes its market success in South Korea is largely due to the novelty of its products, recommendation from a famous celebrity, and the good perception of German brands.
China dietary supplement giant BYHEALTH's revenue in the first half of 2024 fell nearly 18 per cent, which it said was mainly due to the changing consumption landscape and stiff market competition.
Sleep and mental health have been identified as the top consumer concerns in Asia-Pacific (APAC) amid the cost-of-living crisis, which consequently spell opportunities for innovation and category growth, says a consumer intelligence firm.
New Zealand dairy giant Fonterra is looking to further explore innovation opportunities for protein and phospholipids targeted at addressing mobility concerns, including muscle and joint health, amid “massive” ageing populations in Asia-Pacific.
Calcium absorption benefits are resonating strongly with China consumers and this has been a key revenue driver for Haleon’s bone health supplement business in the first half of 2024.
China Nutrition and Health Food Association (CNHFA) has drafted a set of industry standards to measure nicotinamide mononucleotide (NMN) amounts in health supplements.
Indian nutraceutical start-up ReNewtra is adopting front-of-pack labelling, as consumer awareness of product transparency is at an all-time high following recent slews of food safety issues.
Kirin plans to acquire another overseas asset or pour more investment into Blackmores if the deal to acquire FANCL does not go as planned.
